跳至主要内容
临床试验/NCT06737666
NCT06737666招募中1 期

Effects of Tong-Xie-Yao-Fang in Regulating Treg/Th17 Imbalance of Diarrhea-predominant Irritable Bowel Syndrome by Trp-Kyn-AhR Pathway

Xiyuan Hospital of China Academy of Chinese Medical Sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年5月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
60
试验地点
1
主要终点
Fecal metagenomic detection of bacteria associated with Trp metabolism

研究概览

简要总结

Traditional Chinese Medicine focuses on the main pathogenesis of liver depression and spleen deficiency, and treats them from the perspective of soothing the liver and strengthening the spleen to treat on Diarrhea-predominant irritable bowel syndrome (IBS-D) . The classic formula for treating is the Tong-Xie-Yao-Fang (TXYF). Based on metabolomics and metagenomics, the research group studied the intestinal flora and host co metabolism of TXYF in the treatment of diarrhea predominant IBS-D, in order to clarify the mechanism of TXYF in the treatment of IBS-D.

详细描述

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common clinical functional gastrointestinal disease with unclear mechanism, which is mostly induced by emotion. There is no specific treatment for this disease. Traditional Chinese Medicine focuses on the main pathogenesis of liver depression and spleen deficiency, and treats them from the perspective of soothing the liver and strengthening the spleen. The classic formula for treating is the Tong-Xie-Yao-Fang (TXYF).Previous studies of our research group have shown that TXYF can significantly improve the symptoms of abdominal pain and diarrhea in patients with IBS-D, and improve the quality of life of patients. The effectiveness and safety of TXYF in the treatment of IBS-D have been evaluated, and its mechanism of action has also been explored.Modern studies have shown that changes in the local immune microenvironment can affect intestinal immunity and neuroregulation, mucosal barrier damage and abnormal co-metabolism of flora and host, which may be important reasons for the occurrence and development of IBS-D, but the detailed mechanism is unclear.Therefore, based on metabolomics and metagenomics, the research group studied the intestinal flora and host co metabolism of TXYF in the treatment of diarrhea predominant IBS-D, in order to clarify the mechanism of TXYF in the treatment of IBS-D.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • IBS-D patients and healthy volunteers meeting diagnostic criteria;
  • Aged between 18 and 70;
  • Have not taken antibiotics, steroids and other hormones, Chinese herbal preparations (including oral and intravenous injections), microecological preparations or probiotics such as yogurt in the past week.
  • Patients sign informed consent forms and are willing to receive appropriate treatment, and volunteers are willing to cooperate in taking blood, urine, stool and other samples.

排除标准

  • Patients with serious heart, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental diseases;
  • Other organic diseases of the digestive system (such as peptic ulcers), organic diseases such as tumors indicated by recent colonoscopy, or systemic diseases affecting digestive motility (such as hyperthyroidism, diabetes);
  • Need to continue to use drugs that may affect gastrointestinal function (antidiarrheals, antidepressants, anti-anxiety drugs, intestinal flora regulation drugs, antibiotics, etc.);
  • Have a history of drug allergy or severe food allergy for research purposes;
  • Patients under 18 years of age or over 75 years of age and pregnant or lactating women;
  • Severe negative life events occurred during treatment;
  • There is currently any form of psychotherapy in progress;
  • No intention to cooperate.

研究组 & 干预措施

Tong-Xie-Yao-Fang intervention group

Experimental

干预措施: Tong-Xie-Yao-Fang (Drug)

结局指标

主要结局

Fecal metagenomic detection of bacteria associated with Trp metabolism

时间窗: 16weeks

Serum detection by Elisa

时间窗: 16weeks

Serum Trp metabolism was measured by metabolomics

时间窗: 16weeks

Th17/Treg ratio in peripheral blood was measured by flow cytometry

时间窗: 16weeks

Colon tissue was detected by immunofluorescence and histochemistry analysis

时间窗: 16weeks

Foxp3 ,RORrt ,AhR ,IDO1 ,Tyn

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验